Literature DB >> 12948301

Hypoparathyroidism with extensive intracerebral calcification in patients with beta-thalassemia major.

Mehran Karimi1, Farrokh Habibzadeh, Vincenzo De Sanctis.   

Abstract

We report marked intracerebral calcification in eight thalassemic patients with hypoparathyroidism, followed regularly at the Haematology Research Center, Department of Pediatrics, Shiraz, Iran. Their mean age was 16.8 years (range 12-21 years). Six of the eight patients with thalassemia were females. The daily dose of calcitriol was between 0.01 and 0.1 microg/kg b. wt. Calcium-phosphate metabolic control was good or satisfactory in all patients. Three patients had at least one episode of generalized convulsions caused by hypocalcemia, before and during treatment. One patient complained of chronic headache and another patient had a low intelligence quotient. All were on treatment with calcitriol and oral calcium supplementation. The mean serum ferritin concentration was 3225 microg/l (range 2000-6000 microg/l). Calcification was present in the cerebral hemispheres, thalamic nuclei, basal ganglia, the internal capsule, part of the caudate nuclei and the posterior fossa. There was no history of birth asphyxia, head trauma, infections or metabolic diseases in any of the patients. No relationship was observed between the degree of cerebral calcification and the severity of hypoparathyroidism at diagnosis. Our observations stress the importance of a periodic assessment of calcium metabolism, prompt treatment of the endocrinopathy and strict control of calcium metabolism.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12948301     DOI: 10.1515/jpem.2003.16.6.883

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  9 in total

1.  Thalassaemia with extensive intracranial calcifications.

Authors:  Anindita Sinha; Deep N Srivastava
Journal:  Pediatr Radiol       Date:  2008-05-16

2.  Hypoparathyroidism in transfusion-dependent patients with beta-thalassemia.

Authors:  Nicholas G Angelopoulos; Anastasia Goula; Grigorios Rombopoulos; Victoria Kaltzidou; Eugenia Katounda; Dimitrios Kaltsas; George Tolis
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

3.  Osteoporosis syndrome in thalassaemia major: an overview.

Authors:  Meropi Toumba; Nicos Skordis
Journal:  J Osteoporos       Date:  2010-05-26

4.  Vitamin D Receptor (VDR) Gene Polymorphisms (FokI, BsmI) and their Relation to Vitamin D Status in Pediatrics βeta Thalassemia Major.

Authors:  Shereen Mohamed Elhoseiny; Dalia Saber Morgan; Asmaa Mohamed Rabie; Samer Tharwat Bishay
Journal:  Indian J Hematol Blood Transfus       Date:  2015-05-19       Impact factor: 0.900

5.  Diffuse hepatic calcifications in a transfusion-dependent patient with Beta-thalassemia: a case report.

Authors:  Forough Saki; Mohammad Reza Bordbar; Mohammad Hadi Imanieh; Mehran Karimi
Journal:  Iran J Med Sci       Date:  2013-09

6.  Extensive bilateral intracranial calcifications: a case of iatrogenic hypoparathyroidism.

Authors:  Vaso Zisimopoulou; Anna Siatouni; Grigorios Tsoukalos; Antonios Tavernarakis; Stylianos Gatzonis
Journal:  Case Rep Med       Date:  2013-02-24

Review 7.  Vitamin d status in thalassemia major: an update.

Authors:  Ashraf Soliman; Vincenzo De Sanctis; Mohamed Yassin
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-09-02       Impact factor: 2.576

8.  Idiopathic Basal Ganglia Calcification Presented with Impulse Control Disorder.

Authors:  Cem Sahin; Mustafa Levent; Gulhan Akbaba; Bilge Kara; Emine Nese Yeniceri; Betul Battaloglu Inanc
Journal:  Case Rep Endocrinol       Date:  2015-07-13

9.  Hematological and biochemical status of Beta-thalassemia major patients in Bangladesh: A comparative analysis.

Authors:  Md Fazlul Karim; Md Ismail; Akm Mahbub Hasan; Hossain Uddin Shekhar
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2016-01-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.